
If you’re over 50, you’re at increased risk for pneumococcal pneumonia and invasive pneumococcal disease (IPD)
Help protect yourself with CAPVAXIVE
Based on national-level CDC data, CAPVAXIVE is the only vaccine that helps protect against the strains of bacteria that cause
84%*
of US IPD cases in adults over 50


UP TO
52%*
by other pneumococcal conjugate vaccines
*Approximate percentage of IPD cases caused by strains covered by pneumococcal conjugate vaccines based on publicly available, national-level CDC data from 2018-2022. Regional variations may exist.
What is CAPVAXIVE?
CAPVAXIVE is a vaccine for individuals 18 years of age and older to help protect against invasive pneumococcal disease and pneumonia caused by certain types of bacteria called pneumococcus.
Even if you’ve already been vaccinated with certain other pneumococcal vaccines, ask your doctor or pharmacist if CAPVAXIVE could help provide additional protection.
CAPVAXIVE is a vaccine that is specifically designed for adults and helps protect against IPD and pneumococcal pneumonia
I HAVE NOT BEEN previously vaccinated with another pneumococcal vaccine.
I HAVE BEEN previously vaccinated with another pneumococcal vaccine and want to learn more.




One dose. One visit.
Talk to your doctor or pharmacist about CAPVAXIVE today.